Last reviewed · How we verify
Synergy for Staphylococcal Endocarditis
Approved treatments
- Ramycin
Fusidic acid works by inhibiting the function of the bacterial ribosome, preventing the production of essential proteins. - Garamycin · Merck & Co.
- Gentamicin · Merck & Co.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Synergy for Staphylococcal Endocarditis patent landscape — cliff calendar, originator estates, attackable patents
- Synergy for Staphylococcal Endocarditis treatment landscape brief
- Synergy for Staphylococcal Endocarditis treatment updates RSS
Frequently asked questions about Synergy for Staphylococcal Endocarditis
What drugs treat Synergy for Staphylococcal Endocarditis?
Tracked treatments include Ramycin, Garamycin, Gentamicin.
What is the treatment for Synergy for Staphylococcal Endocarditis?
Standard treatment for Synergy for Staphylococcal Endocarditis includes Ramycin, Garamycin, Gentamicin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Synergy for Staphylococcal Endocarditis patent cliff · Synergy for Staphylococcal Endocarditis CI report
- Treatment: Ramycin
- Treatment: Garamycin · Merck & Co.
- Treatment: Gentamicin · Merck & Co.
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing